Dysregulation of JAK-STAT components-including STAT3, JAK1/2, and upstream cytokines such as IL-6-has been linked to CRC aggressiveness, metastatic potential, and resistance to chemotherapy and targeted agents [27,28,29]. Here, JAK1 is linked to colorectal carcinoma.